Inherited gene variants may shape CAR-T therapy benefits and toxic side effects. Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma. But in some patients, the treatment can cause serious side effects.
- Ponto de atenção: inherited.
- Ponto de atenção: gene.
- Ponto de atenção: variants.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
